MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.
Here's a look at some of the top legal news stories for medical device companies this week: ArthroCare ex-CEO faces 30-year sentence for fraud; Shareholders sue Edap following FDA slip; Ex-sales rep wins class action status in lawsuit against Stryker; Another Covidien shareholder sues over Medtronic deal; Respiratory rivals ResMed, BMC each tally wins in Trade Commission ruling
Medtronic reveals that the tax tab for its top executives from its Covidien buyout will near $58 million, apart from the capital gains taxes all shareholders will pay on the $43 billion deal.
Here's a look at some of the top Wall Street stories for medical device companies this week: Covidien snaps up Reverse Medical; Standard & Poor's maintains credit watch on Medtronic over Covidien buy; Allergan can't delay shareholder vote on hostile Valeant bid; Medtronic drops $200M on Dutch DBS firm Sapiens; Nobel Biocare's Q2 profits double as it fields buyout interest
, Danaher Corp.
, Dentsply International Inc.
, Nobel Biocare Holdings AG
, Pershing Square Capital Management
, Reverse Medical Corp.
, Sapiens Brain Steering Stimulation GmbH
, Standard & Poor's
, Valeant Pharmaceuticals
, Allergan Inc.
Covidien acquires Sapheon and its minimally invasive VenaSeal device for treating varicose veins for an undisclosed amount.
Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic.